Is the LION strong enough?

被引：4
作者：
Atallah, David [1 ]
El Rassy, Elie [2 ]
Chahine, Georges [2 ]
机构：
[1] Hotel Dieu France Univ Hosp, St Joseph Univ, Dept Obstet Gynecol, Fac Med, Beirut, Lebanon
[2] Hotel Dieu France Univ Hosp, St Joseph Univ, Dept Med Oncol, Fac Med, Beirut, Lebanon
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 21期
关键词：
advanced ovarian cancer; LION trial; lymphadenectomy; residual disease; LYMPH-NODE METASTASIS; EPITHELIAL OVARIAN-CANCER; LYMPHADENECTOMY; RESECTION;
D O I：
10.2217/fon-2017-0292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1835 / 1837
页数：3
相关论文
共 15 条
[1]   Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer [J].
Ataseven, Beyhan ;
Grimm, Christoph ;
Harter, Philipp ;
Prader, Sonia ;
Traut, Alexander ;
Heitz, Florian ;
du Bois, Andreas .
GYNECOLOGIC ONCOLOGY, 2014, 135 (03) :435-440
[2]   The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13,918 patients [J].
Chan, J. K. ;
Urban, R. ;
Hu, J. M. ;
Shin, J. Y. ;
Husain, A. ;
Teng, N. N. ;
Berek, J. S. ;
Osann, K. ;
Kapp, D. S. .
BRITISH JOURNAL OF CANCER, 2007, 96 (12) :1817-1822
[3]   2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [J].
du Bois, A ;
Quinn, M ;
Thigpen, T ;
Vermorken, J ;
Avall-Lundqvist, E ;
Bookman, M ;
Bowtell, D ;
Brady, M ;
Casado, A ;
Cervantes, A ;
Eisenhauer, E ;
Friedlaender, M ;
Fujiwara, K ;
Grenman, S ;
Guastalla, JP ;
Harper, P ;
Hogberg, T ;
Kaye, S ;
Kitchener, H ;
Kristensen, G ;
Mannel, R ;
Meier, W ;
Miller, B ;
Neijt, JP ;
Oza, A ;
Ozols, R ;
Parmar, M ;
Pecorelli, S ;
Pfisterer, J ;
Poveda, A ;
Provencher, D ;
Pujade-Lauraine, E ;
Randall, M ;
Rochon, J ;
Rustin, G ;
Sagae, S ;
Stehman, F ;
Stuart, G ;
Trimble, E ;
Vasey, P ;
Vergote, I ;
Verheijen, R ;
Wagner, U .
ANNALS OF ONCOLOGY, 2005, 16 :7-12
[4]   Potential Role of Lymphadenectomy in Advanced Ovarian Cancer: A Combined Exploratory Analysis of Three Prospectively Randomized Phase III Multicenter Trials [J].
du Bois, Andreas ;
Reuss, Alexander ;
Harter, Philipp ;
Pujade-Lauraine, Eric ;
Ray-Coquard, Isabelle ;
Pfisterer, Jacobus .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1733-1739
[5]   The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer [J].
Eisenkop, SM ;
Spirtos, NM .
GYNECOLOGIC ONCOLOGY, 2001, 82 (01) :143-149
[6]   Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies [J].
Gao, Jingwei ;
Yang, Xiaoqing ;
Zhang, Yuquan .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) :49-60
[7]   LION: Lymphadenectomy in ovarian neoplasms-A prospective randomized AGO study group led gynecologic cancer intergroup trial [J].
Harter, Philipp ;
Sehouli, Jalid ;
Lorusso, Domenica ;
Reuss, Alexander ;
Vergote, Ignace ;
Marth, Christian ;
Kim, Jae Weon ;
Raspagliesi, Francesco ;
Lampe, Boern ;
Landoni, Fabio ;
Meier, Werner ;
Cibula, David ;
Mustea, Alexander ;
Mahner, Sven ;
Runnebaum, Ingo B. ;
Schmalfeldt, Barbara ;
Burges, Alexander ;
Kimmig, Rainer ;
Wagner, Uwe A. G. ;
Du Bois, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21254, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21654, 10.3322/caac.21601]
[9]  
Keyver-Paik MD, 2016, ANTICANCER RES, V36, P1815
[10]  
Morice P, 2004, EUR J GYNAECOL ONCOL, V25, P169
12